Granulomatous–lymphocytic interstitial lung disease
| Granulomatous–lymphocytic interstitial lung disease | |
|---|---|
| Synonyms | GLILD |
| Pronounce | N/A |
| Specialty | Pulmonology, Immunology |
| Symptoms | Cough, dyspnea, fatigue, weight loss |
| Complications | Pulmonary fibrosis, respiratory failure |
| Onset | Variable |
| Duration | Chronic |
| Types | N/A |
| Causes | Associated with Common variable immunodeficiency |
| Risks | Immunodeficiency disorders |
| Diagnosis | High-resolution computed tomography, lung biopsy |
| Differential diagnosis | Sarcoidosis, Hypersensitivity pneumonitis, Lymphocytic interstitial pneumonia |
| Prevention | N/A |
| Treatment | Corticosteroids, immunosuppressive therapy |
| Medication | N/A |
| Prognosis | Variable, depends on response to treatment |
| Frequency | Rare |
| Deaths | N/A |
Granulomatous–lymphocytic interstitial lung disease (GLILD) is a rare lung condition that is often associated with Common variable immunodeficiency (CVID). It is characterized by the formation of granulomas and lymphocytic infiltrates in the lungs.
Symptoms[edit]
The symptoms of GLILD can vary greatly from person to person. Some people may have no symptoms at all, while others may experience severe and debilitating symptoms. Common symptoms include:
Causes[edit]
The exact cause of GLILD is unknown. However, it is often associated with CVID, a type of primary immunodeficiency that affects the body's ability to produce antibodies. It is thought that the immune system's inability to properly respond to infections may lead to the formation of granulomas and lymphocytic infiltrates in the lungs.
Diagnosis[edit]
Diagnosis of GLILD can be challenging due to its rarity and the nonspecific nature of its symptoms. It is often diagnosed through a combination of clinical examination, imaging studies, and lung biopsy.
Treatment[edit]
Treatment for GLILD typically involves immunosuppressive therapy to reduce inflammation and prevent further damage to the lungs. This may include corticosteroids, rituximab, and azathioprine. In severe cases, lung transplantation may be considered.
Prognosis[edit]
The prognosis for individuals with GLILD can vary greatly depending on the severity of the disease and the individual's response to treatment. With appropriate treatment, many individuals can lead a normal life.
See also[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


